BMY vs CMP · P/E 17, rev $48.19B vs rev $1.12B
Bristol-Myers Squibb Company (BMY) versus Compass Minerals International Inc (CMP) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Compass Minerals International Inc (CMP) is a other industrial metals & mining company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CMP revenue for 2024-09-30 was $1.12B. Net income was -$206.1M. Revenue was down 7.2% from 2023-09-30 to 2024-09-30. CMP currently screens at market cap $916.5M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CMP currently screens at market cap $916.5M.
Not investment advice. Open the BMY and CMP stock pages for the full models.
Not investment advice.